Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 73

1.

Donor-targeted Serotherapy as a Rescue Therapy for Steroid-resistant Acute GVHD after HLA-mismatched Kidney Transplantation.

Zuber J, Boyer O, Neven B, Jollet I, Renac V, Berthaud R, Levy R, Lamarthée B, Visentin J, Marchal A, Gouge-Biebuyck N, Godron-Dubrasquet A, Aladjidi N, Ould Rabah M, Winter S, Léon J, Dussiot M, Rabant M, Krid S, Krug P, Charbit M, Lacaille F, André I, Cavazzana M, Llanas B, Allard L, Pirenne F, Gross S, Djoudi R, Tiberghien P, Taupin JL, Blanche S, Salomon R.

Am J Transplant. 2020 Feb 17. doi: 10.1111/ajt.15827. [Epub ahead of print]

PMID:
32065452
2.

School level of children carrying a HNF1B variant or a deletion.

Laliève F, Decramer S, Heidet L, Baudouin V, Lahoche A, Llanas B, Cochat P, Tenenbaum J, Lavocat MP, Eckart P, Broux F, Roussey G, Cloarec S, Vrillon I, Dunand O, Bessenay L, Tsimaratos M, Nobili F, Pietrement C, De Parscau L, Bonneville V, Rodier N, Saint-Martin C, Chassaing N, Michel-Calemard L, Moriniere V, Bellanné-Chantelot C, Bahans C, Guigonis V.

Eur J Hum Genet. 2020 Jan;28(1):56-63. doi: 10.1038/s41431-019-0490-6. Epub 2019 Sep 3.

PMID:
31481685
3.

Outcome of children with Shiga toxin-associated haemolytic uraemic syndrome treated with eculizumab: a matched cohort study.

Monet-Didailler C, Chevallier A, Godron-Dubrasquet A, Allard L, Delmas Y, Contin-Bordes C, Brissaud O, Llanas B, Harambat J.

Nephrol Dial Transplant. 2019 Aug 14. pii: gfz158. doi: 10.1093/ndt/gfz158. [Epub ahead of print]

PMID:
31411695
4.

Targeted gene therapy in human-induced pluripotent stem cells from a patient with primary hyperoxaluria type 1 using CRISPR/Cas9 technology.

Estève J, Blouin JM, Lalanne M, Azzi-Martin L, Dubus P, Bidet A, Harambat J, Llanas B, Moranvillier I, Bedel A, Moreau-Gaudry F, Richard E.

Biochem Biophys Res Commun. 2019 Oct 1;517(4):677-683. doi: 10.1016/j.bbrc.2019.07.109. Epub 2019 Aug 8.

PMID:
31402115
5.

Generation of induced pluripotent stem cells-derived hepatocyte-like cells for ex vivo gene therapy of primary hyperoxaluria type 1.

Estève J, Blouin JM, Lalanne M, Azzi-Martin L, Dubus P, Bidet A, Harambat J, Llanas B, Moranvillier I, Bedel A, Moreau-Gaudry F, Richard E.

Stem Cell Res. 2019 Jul;38:101467. doi: 10.1016/j.scr.2019.101467. Epub 2019 May 21.

6.

Complement Gene Variants and Shiga Toxin-Producing Escherichia coli-Associated Hemolytic Uremic Syndrome: Retrospective Genetic and Clinical Study.

Frémeaux-Bacchi V, Sellier-Leclerc AL, Vieira-Martins P, Limou S, Kwon T, Lahoche A, Novo R, Llanas B, Nobili F, Roussey G, Cailliez M, Ulinski T, Deschênes G, Alberti C, Weill FX, Mariani P, Loirat C.

Clin J Am Soc Nephrol. 2019 Mar 7;14(3):364-377. doi: 10.2215/CJN.05830518. Epub 2019 Jan 23.

PMID:
30674459
7.

Hemolytic uremic syndrome associated with Bordetella pertussis infection in a 2-month-old infant carrying a pathogenic variant in complement factor H.

Madden I, Roumenina LT, Langlois-Meurinne H, Guichoux J, Llanas B, Frémeaux-Bacchi V, Harambat J, Godron-Dubrasquet A.

Pediatr Nephrol. 2019 Mar;34(3):533-537. doi: 10.1007/s00467-018-4174-1. Epub 2018 Dec 17.

PMID:
30560448
8.

Long-term outcome of diarrhea-associated hemolytic uremic syndrome is poorly related to markers of kidney injury at 1-year follow-up in a population-based cohort.

Monet-Didailler C, Godron-Dubrasquet A, Madden I, Delmas Y, Llanas B, Harambat J.

Pediatr Nephrol. 2019 Apr;34(4):657-662. doi: 10.1007/s00467-018-4131-z. Epub 2018 Oct 27.

PMID:
30368614
9.

Eculizumab treatment in severe pediatric STEC-HUS: a multicenter retrospective study.

Percheron L, Gramada R, Tellier S, Salomon R, Harambat J, Llanas B, Fila M, Allain-Launay E, Lapeyraque AL, Leroy V, Adra AL, Bérard E, Bourdat-Michel G, Chehade H, Eckart P, Merieau E, Piètrement C, Sellier-Leclerc AL, Frémeaux-Bacchi V, Dimeglio C, Garnier A.

Pediatr Nephrol. 2018 Aug;33(8):1385-1394. doi: 10.1007/s00467-018-3903-9. Epub 2018 Mar 23.

PMID:
29572749
10.

Prevalence of Novel MAGED2 Mutations in Antenatal Bartter Syndrome.

Legrand A, Treard C, Roncelin I, Dreux S, Bertholet-Thomas A, Broux F, Bruno D, Decramer S, Deschenes G, Djeddi D, Guigonis V, Jay N, Khalifeh T, Llanas B, Morin D, Morin G, Nobili F, Pietrement C, Ryckewaert A, Salomon R, Vrillon I, Blanchard A, Vargas-Poussou R.

Clin J Am Soc Nephrol. 2018 Feb 7;13(2):242-250. doi: 10.2215/CJN.05670517. Epub 2017 Nov 16.

11.

Clinical and genetic heterogeneity in familial steroid-sensitive nephrotic syndrome.

Dorval G, Gribouval O, Martinez-Barquero V, Machuca E, Tête MJ, Baudouin V, Benoit S, Chabchoub I, Champion G, Chauveau D, Chehade H, Chouchane C, Cloarec S, Cochat P, Dahan K, Dantal J, Delmas Y, Deschênes G, Dolhem P, Durand D, Ekinci Z, El Karoui K, Fischbach M, Grunfeld JP, Guigonis V, Hachicha M, Hogan J, Hourmant M, Hummel A, Kamar N, Krummel T, Lacombe D, Llanas B, Mesnard L, Mohsin N, Niaudet P, Nivet H, Parvex P, Pietrement C, de Pontual L, Noble CP, Ribes D, Ronco P, Rondeau E, Sallee M, Tsimaratos M, Ulinski T, Salomon R, Antignac C, Boyer O.

Pediatr Nephrol. 2018 Mar;33(3):473-483. doi: 10.1007/s00467-017-3819-9. Epub 2017 Oct 23.

PMID:
29058154
12.

[Solitary kidney: Management and outcome].

Godron-Dubrasquet A, Didailler C, Harambat J, Llanas B.

Arch Pediatr. 2017 Nov;24(11):1158-1163. doi: 10.1016/j.arcped.2017.08.016. Epub 2017 Sep 20. French.

PMID:
28939448
13.

Clinical and Genetic Spectrum of Bartter Syndrome Type 3.

Seys E, Andrini O, Keck M, Mansour-Hendili L, Courand PY, Simian C, Deschenes G, Kwon T, Bertholet-Thomas A, Bobrie G, Borde JS, Bourdat-Michel G, Decramer S, Cailliez M, Krug P, Cozette P, Delbet JD, Dubourg L, Chaveau D, Fila M, Jourde-Chiche N, Knebelmann B, Lavocat MP, Lemoine S, Djeddi D, Llanas B, Louillet F, Merieau E, Mileva M, Mota-Vieira L, Mousson C, Nobili F, Novo R, Roussey-Kesler G, Vrillon I, Walsh SB, Teulon J, Blanchard A, Vargas-Poussou R.

J Am Soc Nephrol. 2017 Aug;28(8):2540-2552. doi: 10.1681/ASN.2016101057. Epub 2017 Apr 5.

14.

Late diagnosis of primary hyperoxaluria type III.

Richard E, Blouin JM, Harambat J, Llanas B, Bouchet S, Acquaviva C, de la Faille R.

Ann Clin Biochem. 2017 May;54(3):406-411. doi: 10.1177/0004563216677101. Epub 2017 Jan 10.

PMID:
27742850
15.

Mycophenolic Acid Pharmacokinetics and Relapse in Children with Steroid-Dependent Idiopathic Nephrotic Syndrome.

Tellier S, Dallocchio A, Guigonis V, Saint-Marcoux F, Llanas B, Ichay L, Bandin F, Godron A, Morin D, Brochard K, Gandia P, Bouchet S, Marquet P, Decramer S, Harambat J.

Clin J Am Soc Nephrol. 2016 Oct 7;11(10):1777-1782. doi: 10.2215/CJN.00320116. Epub 2016 Jul 21.

16.

Homozygous 16p13.11 duplication associated with mild intellectual disability and urinary tract malformations in two siblings born from consanguineous parents.

Houcinat N, Llanas B, Moutton S, Toutain J, Cailley D, Arveiler B, Combe C, Lacombe D, Rooryck C.

Am J Med Genet A. 2015 Nov;167A(11):2714-9. doi: 10.1002/ajmg.a.37212. Epub 2015 Jun 26.

PMID:
26114937
17.

[The "ressort" workshop: when a child plays a role in the management of his kidney transplant].

Llanas B, Lucats F, Harambat J, Godron A.

Arch Pediatr. 2015 May;22(5 Suppl 1):13-4. doi: 10.1016/S0929-693X(15)30008-7. French. No abstract available.

PMID:
26112499
18.

[Significance of the urine strip test in case of stunted growth].

Bertholet-Thomas A, Llanas B, Servais A, Bendelac N, Goizet C, Choukroun G, Novo R, Decramer S.

Arch Pediatr. 2015 Jul;22(7):756-62. doi: 10.1016/j.arcped.2015.04.016. Epub 2015 Jun 3. French.

PMID:
26047745
19.

[Cystinosis in adults: A systemic disease].

Servais A, Goizet C, Bertholet-Thomas A, Decramer S, Llanas B, Choukroun G, Novo R.

Nephrol Ther. 2015 Jun;11(3):152-9. doi: 10.1016/j.nephro.2014.12.001. Epub 2015 Mar 11. Review. French.

PMID:
25769364
20.

Towards a new point of view on the phenotype of patients with a 17q12 microdeletion syndrome.

Laffargue F, Bourthoumieu S, Llanas B, Baudouin V, Lahoche A, Morin D, Bessenay L, De Parscau L, Cloarec S, Delrue MA, Taupiac E, Dizier E, Laroche C, Bahans C, Yardin C, Lacombe D, Guigonis V.

Arch Dis Child. 2015 Mar;100(3):259-64. doi: 10.1136/archdischild-2014-306810. Epub 2014 Oct 16.

PMID:
25324567
21.

[Clinical and biochemical characterization of childhood urolithiasis].

Giraudon A, Richard E, Godron A, Bouty A, Dobremez E, Barat P, Blouin JM, Llanas B, Harambat J.

Arch Pediatr. 2014 Dec;21(12):1322-9. doi: 10.1016/j.arcped.2014.08.027. Epub 2014 Oct 5. French.

PMID:
25287140
22.

Atypical hematologic and renal manifestations in neurofibromatosis type I: coincidence or pathophysiological link?

Van-Gils J, Harambat J, Jubert C, Vidaud D, Llanas B, Perel Y, Lacombe D, Goizet C.

Eur J Med Genet. 2014 Nov-Dec;57(11-12):639-42. doi: 10.1016/j.ejmg.2014.09.001. Epub 2014 Sep 16.

PMID:
25234363
23.

Outbreak of Escherichia coli O104:H4 haemolytic uraemic syndrome in France: outcome with eculizumab.

Delmas Y, Vendrely B, Clouzeau B, Bachir H, Bui HN, Lacraz A, Hélou S, Bordes C, Reffet A, Llanas B, Skopinski S, Rolland P, Gruson D, Combe C.

Nephrol Dial Transplant. 2014 Mar;29(3):565-72. doi: 10.1093/ndt/gft470. Epub 2013 Nov 28.

24.

Intestinal microsporidiosis due to Enterocytozoon bieneusi in a pediatric kidney transplant recipient successfully treated with fumagillin.

Godron A, Accoceberry I, Couret A, Llanas B, Harambat J.

Transplantation. 2013 Oct 27;96(8):e66-7. doi: 10.1097/TP.0b013e3182a902e7. No abstract available.

PMID:
24132119
25.

[Secondary hyperoxaluria and nephrocalcinosis due to ethylene glycol poisoning].

Monet C, Richard E, Missonnier S, Rebouissoux L, Llanas B, Harambat J.

Arch Pediatr. 2013 Aug;20(8):863-6. doi: 10.1016/j.arcped.2013.05.011. Epub 2013 Jul 1. French.

PMID:
23827374
26.

Hemolytic uremic syndrome complicating Mycoplasma pneumoniae infection.

Godron A, Pereyre S, Monet C, Llanas B, Harambat J.

Pediatr Nephrol. 2013 Oct;28(10):2057-60. doi: 10.1007/s00467-013-2541-5. Epub 2013 Jun 26.

PMID:
23800801
27.

Recessive mutations in DGKE cause atypical hemolytic-uremic syndrome.

Lemaire M, Frémeaux-Bacchi V, Schaefer F, Choi M, Tang WH, Le Quintrec M, Fakhouri F, Taque S, Nobili F, Martinez F, Ji W, Overton JD, Mane SM, Nürnberg G, Altmüller J, Thiele H, Morin D, Deschenes G, Baudouin V, Llanas B, Collard L, Majid MA, Simkova E, Nürnberg P, Rioux-Leclerc N, Moeckel GW, Gubler MC, Hwa J, Loirat C, Lifton RP.

Nat Genet. 2013 May;45(5):531-6. doi: 10.1038/ng.2590. Epub 2013 Mar 31.

28.

Long-term outcome of children treated with rituximab for idiopathic nephrotic syndrome.

Tellier S, Brochard K, Garnier A, Bandin F, Llanas B, Guigonis V, Cailliez M, Pietrement C, Dunand O, Nathanson S, Bertholet-Thomas A, Ichay L, Decramer S.

Pediatr Nephrol. 2013 Jun;28(6):911-8. doi: 10.1007/s00467-012-2406-3. Epub 2013 Jan 23.

PMID:
23340857
29.

Prediction of steroid-sparing agent use in childhood idiopathic nephrotic syndrome.

Harambat J, Godron A, Ernould S, Rigothier C, Llanas B, Leroy S.

Pediatr Nephrol. 2013 Apr;28(4):631-8. doi: 10.1007/s00467-012-2365-8. Epub 2012 Nov 21.

PMID:
23179197
30.

Renal outcome in long-term survivors from severe acute kidney injury in childhood.

Viaud M, Llanas B, Harambat J.

Pediatr Nephrol. 2012 Jan;27(1):151-2; author reply 153. doi: 10.1007/s00467-011-2016-5. Epub 2011 Sep 27. No abstract available.

PMID:
21947273
31.

Household transmission of haemolytic uraemic syndrome associated with Escherichia coli O104:H4, south-western France, June 2011.

Aldabe B, Delmas Y, Gault G, Vendrely B, Llanas B, Charron M, Castor C, Ong N, Weill F, Mariani-Kurkdjian P, Terrier F, Desjardin M, Simoes J, Le Bihan B, Combe C, Rolland P.

Euro Surveill. 2011 Aug 4;16(31). pii: 19934.

32.

[Idiopathic nephrotic syndrome in children: Incidence, clinical presentation, and outcome in the county of Gironde, France].

Ernould S, Godron A, Nelson JR, Rigothier C, Llanas B, Harambat J.

Arch Pediatr. 2011 May;18(5):522-8. doi: 10.1016/j.arcped.2011.02.012. Epub 2011 Apr 1. French.

PMID:
21458969
33.

A 10-year-old boy with dark urine and acute kidney injury.

Joussain C, Lamireau D, Espil-Taris C, De Précigout V, Vianey-Saban C, Llanas B, Harambat J.

Pediatr Nephrol. 2011 Aug;26(8):1229-33. doi: 10.1007/s00467-011-1763-7. Epub 2011 Jan 27. No abstract available.

PMID:
21271260
34.

Severe transient ADAMTS13 deficiency in pneumococcal-associated hemolytic uremic syndrome.

Pelras S, Delmas Y, Lamireau D, Villega F, Nolent P, Ryman A, Llanas B, Brissaud O, Harambat J.

Pediatr Nephrol. 2011 Apr;26(4):631-5. doi: 10.1007/s00467-010-1721-9. Epub 2010 Dec 15.

PMID:
21161282
35.

Successful treatment with rituximab for acute refractory thrombotic thrombocytopenic purpura related to acquired ADAMTS13 deficiency: a pediatric report and literature review.

Harambat J, Lamireau D, Delmas Y, Ryman A, Llanas B, Brissaud O.

Pediatr Crit Care Med. 2011 Mar;12(2):e90-3. doi: 10.1097/PCC.0b013e3181e89f8f.

PMID:
20625343
36.

Long-term effects of cyclophosphamide therapy in steroid-dependent or frequently relapsing idiopathic nephrotic syndrome.

Cammas B, Harambat J, Bertholet-Thomas A, Bouissou F, Morin D, Guigonis V, Bendeddouche S, Afroukh-Hacini N, Cochat P, Llanas B, Decramer S, Ranchin B.

Nephrol Dial Transplant. 2011 Jan;26(1):178-84. doi: 10.1093/ndt/gfq405. Epub 2010 Jul 7.

PMID:
20610527
37.

Renal impairment in children with cystic fibrosis.

Andrieux A, Harambat J, Bui S, Nacka F, Iron A, Llanas B, Fayon M.

J Cyst Fibros. 2010 Jul;9(4):263-8. doi: 10.1016/j.jcf.2010.03.006. Epub 2010 Apr 21.

38.

Effect of conservative treatment on the renal outcome of children with primary hyperoxaluria type 1.

Fargue S, Harambat J, Gagnadoux MF, Tsimaratos M, Janssen F, Llanas B, Berthélémé JP, Boudailliez B, Champion G, Guyot C, Macher MA, Nivet H, Ranchin B, Salomon R, Taque S, Rolland MO, Cochat P.

Kidney Int. 2009 Oct;76(7):767-73. doi: 10.1038/ki.2009.237. Epub 2009 Jul 1.

39.

[What is new in dysplastic multicystic kidney disease?].

Harambat J, Dobremez E, Llanas B.

Arch Pediatr. 2009 Jun;16(6):696-7. doi: 10.1016/S0929-693X(09)74116-8. French. No abstract available.

PMID:
19541134
40.

[Phenotypic heterogeneity of TCF2's gene mutation coding for HNF-1 beta in a single family].

Rigothier C, Harambat J, Llanas B, Subra JF, Combe C.

Nephrol Ther. 2009 Jul;5(4):287-91. doi: 10.1016/j.nephro.2009.02.009. Epub 2009 Apr 1. French.

PMID:
19346182
41.

Acute renal cortical necrosis due to acquired antiprotein S antibodies.

Larakeb AS, Evrard S, Louillet F, Kwon T, Djaffar H, Llanas B, Deschênes G, Hurtaud-Roux MF, Baudouin V.

Pediatr Nephrol. 2009 Jan;24(1):207-9. doi: 10.1007/s00467-008-0967-y. Epub 2008 Sep 6.

PMID:
18777044
42.

[Indications and results of intradetrusor of botulinum toxin type A injections in children].

Dobremez E, Llanas B, Shao E, de Seze M.

Prog Urol. 2008 Mar;18(3):168-71. doi: 10.1016/j.purol.2007.10.014. Epub 2008 Mar 26. French.

PMID:
18472070
43.

Rituximab treatment for severe steroid- or cyclosporine-dependent nephrotic syndrome: a multicentric series of 22 cases.

Guigonis V, Dallocchio A, Baudouin V, Dehennault M, Hachon-Le Camus C, Afanetti M, Groothoff J, Llanas B, Niaudet P, Nivet H, Raynaud N, Taque S, Ronco P, Bouissou F.

Pediatr Nephrol. 2008 Aug;23(8):1269-79. doi: 10.1007/s00467-008-0814-1. Epub 2008 May 9.

PMID:
18465150
44.

[Chikungunya in paediatrics: epidemic of 2005-2006 in Saint-Denis, Reunion Island].

Ernould S, Walters H, Alessandri JL, Llanas B, Jaffar MC, Robin S, Attali T, Ramful D, Combes JC.

Arch Pediatr. 2008 Mar;15(3):253-62. doi: 10.1016/j.arcped.2007.10.019. Epub 2008 Mar 5. French.

PMID:
18321688
45.

High NPHP1 and NPHP6 mutation rate in patients with Joubert syndrome and nephronophthisis: potential epistatic effect of NPHP6 and AHI1 mutations in patients with NPHP1 mutations.

Tory K, Lacoste T, Burglen L, Morinière V, Boddaert N, Macher MA, Llanas B, Nivet H, Bensman A, Niaudet P, Antignac C, Salomon R, Saunier S.

J Am Soc Nephrol. 2007 May;18(5):1566-75. Epub 2007 Apr 4.

46.

[Epidemiological characteristics of children less than 15 years hospitalized at the children hospital of Bordeaux for the diagnosis and initial treatment of type 1 diabetes].

Boulard S, At L, Llanas B, Barat P.

Arch Pediatr. 2007 Feb;14(2):198-9. Epub 2006 Dec 19. French. No abstract available.

PMID:
17182228
47.

Rituximab therapy for childhood-onset systemic lupus erythematosus.

Willems M, Haddad E, Niaudet P, Koné-Paut I, Bensman A, Cochat P, Deschênes G, Fakhouri F, Leblanc T, Llanas B, Loirat C, Pillet P, Ranchin B, Salomon R, Ulinski T, Bader-Meunier B; French Pediatric-Onset SLE Study Group.

J Pediatr. 2006 May;148(5):623-627. Erratum in: J Pediatr. 2006 Oct;149(4):586.

PMID:
16737873
48.

The parapelvic renal cyst. A rare aetiology of blood hypertension in children.

Dobremez E, Llanas B, Harper L, Bondonny JM.

Eur J Pediatr Surg. 2006 Feb;16(1):61-3.

PMID:
16544231
49.

[Acute leptospirosis in children in Reunion Island: a retrospective review of 16 cases].

Agésilas F, Gey F, Monbrunt A, Combes JC, Llanas B, Schlossmacher P, Gaüzère BA.

Arch Pediatr. 2005 Sep;12(9):1344-8. French.

PMID:
15994067
50.

[Parvovirus B19 thrombocytopenic purpura complicated with a cerebral hemorrhage].

Tourneux P, Jouvencel P, Micheau M, Jouvencel AC, Chateil JF, Barba G, Letavernier B, Llanas B.

Arch Pediatr. 2005 Mar;12(3):281-3. French.

PMID:
15734124

Supplemental Content

Loading ...
Support Center